化工社化工社 化学情報印刷レポート · 研究参考用
HRID 255811作成日:2026年10月27日
1-Butanol → 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-11-propyl-, (S)-
https://huagongshe.com/reaction/255811
関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | 1-Butanol | HCID 263 | — |
| 反応物 | Hydrogen Peroxide | HCID 784 | — |
| 反応物 | Sulfuric Acid | HCID 1118 | — |
| 反応物 | Camptothecin | HCID 24360 | — |
| 溶媒 | Water | HCID 962 | — |
| 生成物 | 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-11-propyl-, (S)- | HCID 149612 | — |
反応手順
Ferrous sulfate heptahydrate (2.8 g, 10.1 m-mol) and 1-butanol (3 ml, 43 m-mol) were dissolved in water (30 ml). Camptothecin (500 mg, 1.43 m-mol) was suspended in the solution and dissolved therein by addition of concentrated sulfuric acid (15 ml). To this solution was added dropwise under ice-cooling and agitation a 30% aqueous solution of hydrogen peroxide (1.1 ml, 10.1 m-mol) in small portions. The agitation was continued for 4 hours at room temperature. The reaction mixture was diluted with ice water (1.5 l) and extracted with chloroform (2 l). The chloroform layer was dried with magnesium sulfate, filtered and evaporated until dryness under reduced pressure. The residue was subjected to column chromatography (chloroform) through silica gel (15 g) to effect separation and purification of the product which was then recrystallized from n-hexane-chloroform whereby 110 mg (21.0%) of the objective compound were obtained as light yellow white needle crystals. M.P. 260°-261° C.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 特許番号 | USRE032518 |
|---|
| 出典データセット | uspto-grants-1987_10 |
|---|
| ORD ID | ord-79a77d71353d483fafa1842e7a6b9e16 |
|---|
| 出典メモ | uspto-grants-1987_10 |
|---|